The Making Of Nepal’s Immunization Law

Financial independence for Nepal’s immunization program is now within reach for the first time in history. On January 26, 2016, President Bidya Devi Bhandari of Nepal signed into law a long-awaited immunization bill. This law will improve oversight of immunization services, set tighter standards for vaccine testing and use, and perhaps most importantly, change the way Nepal finances its immunization program. Transitioning From Gavi Support Like many nations, Nepal currently depends on financial support from Gavi, the Vaccine Alliance, to fund 60-70 percent of its vaccine purchases. Nepal’s Finance Minister has stated that the country is expected to graduate from low-income to middle-income status by 2022, at which point it will no longer be eligible for Gavi support. This gives the government only a few years to establish reliable, domestic financing for immunization. Nepal’s immunization law establishes two methods for financing its immunization program. First, it mandates that the government allocate adequate funding for immunization to the National Immunization Fund, which will be collected through general taxation. To determine the amount, immunization advocates will bring evidence to the Ministry of Finance demonstrating how much money the immunization program needs to sustain current vaccine coverage and associated program operations, and purchase new vaccines. So far, the government has allocated 60 million Nepalese rupees (approximately US $550,000) ...
Source: Health Affairs Blog - Category: Health Management Authors: Tags: Costs and Spending Featured Global Health Population Health Gavi Kathmandu Declaration Nepal Sustainable Immunization Financing Program vaccines Source Type: blogs

Related Links:

Publication date: Available online 28 May 2020Source: Veterinary MicrobiologyAuthor(s): Yuying Han, Libao Xie, Mengqi Yuan, Yuteng Ma, Huimin Sun, Yuan Sun, Yongfeng Li, Hua-Ji Qiu
Source: Veterinary Microbiology - Category: Veterinary Research Source Type: research
The chief executive of AstraZeneca, which is developing a leading coronavirus vaccine with Oxford University, said it is too early to deliberately expose vaccine trial participants to the pathogen, but it may become an option if ongoing trials hit a snag.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Authors: Lum C, Prenen H, Body A, Lam M, Segelov E Abstract INTRODUCTION: Anal cancer is a rare malignancy with increasing incidence, notably in women. This disease is highly associated with HPV infection and its incidence and mortality are currently rising. Most patients present with localized disease which has a high survival after definitive treatment with chemoradiation. For patients who develop metastatic disease or present with this de novo, survival is poor. AREAS COVERED: This review provides a summary of current literature on anal cancer. With a focus on women, this includes current epidemiological tre...
Source: Expert Review of Gastroenterology and Hepatology - Category: Gastroenterology Tags: Expert Rev Gastroenterol Hepatol Source Type: research
Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
by Jamie Webb MA, MSci  ‘An experimental vaccine against the coronavirus showed encouraging results in very early testing, triggering hoped-for immune responses in eight healthy, middle-aged volunteers, its maker announced Monday.’ Readers of the Associated Press’s lead paragraph on Moderna’s vaccine candidate for COVID-19 could be forgiven for getting excited. However, the same article ends with this caveat, “The results have not been published and are only from the first of three stages of testing that vaccines and drugs normally undergo.” Rather than published data, the...
Source: blog.bioethics.net - Category: Medical Ethics Authors: Tags: Clinical Trials & Studies Featured Posts Media #covid19 #diaryofaplagueyear COVID-19 Source Type: blogs
A panel of the European health regulator on Friday recommended approving Johnson&Johnson's two-dose experimental vaccine for Ebola in the European Union.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
CONCLUSIONS: This new disease is pushing the scientific community to develop swiftly a safe and effective vaccine. Notwithstanding the limitations of our analysis, given by the absence of available results, we try to provide a comprehensive view of the ongoing clinical trials in humans. Our analysis reveals a worldwide effort of both scientists and enterprises to achieve one of the most challenging goals of our century. PMID: 32456404 [PubMed - as supplied by publisher]
Source: Panminerva Medica - Category: General Medicine Tags: Panminerva Med Source Type: research
Sanofi's head of vaccines David Loew will quit to become chief executive of Ipsen from July 1, the two French drugmakers said on Friday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Regional efforts to control the spread of COVID-19 have so far proven successful. Image Credit: Pacific CommunityBy William W. EllisTORONTO, May 29 2020 (IPS) By now, the impact of COVID19 on our daily lives has been well documented, especially in advanced economies. Anxiety about the future continues to grow everywhere. Much of the corporate news coverage we consume has focused on the toll this pandemic will take on mainland countries. Often neglected, however, is the unique position Pacific Island States find themselves in. Globally, there are close to 6 million confirmed cases of COVID19. According to the Pacific Commu...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Climate Change Economy & Trade Featured Financial Crisis Global Headlines Health Humanitarian Emergencies Labour Multimedia Podcast TerraViva United Nations Secretariat of the Pacific Community (SPC) Source Type: news
Publication date: Available online 27 May 2020Source: Fish &Shellfish ImmunologyAuthor(s): Peiwen Wu, Shihui Zhou, Zehui Su, Chang Liu, Fuyuan Zeng, Huanying Pang, Miao Xie, Jichang Jian
Source: Fish and Shellfish Immunology - Category: Biology Source Type: research
More News: American Health | Blogging | Budgets | Child Development | Children | Funding | Government | Graduation | Health | Health Medicine & Bioethics Commentators | International Medicine & Public Health | Learning | Lessons | Nepal Health | Politics | Tax | Universities & Medical Training | Vaccines | WHO | Women